Want to join the conversation?
Medical technologies company $BCR's 2Q16 net sales grew 8% on an as-reported basis and up 9% on a constant currency basis over 2Q15. Organic growth rate was about 6.4% in the quarter. US net sales rose 7%, with Europe up 7%, Japan up 29%, and other international businesses up 15% on a constant currency basis.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.